OriGene Technologies Raises $16M

OriGene plans to use the funds to help build its TrueMAB monoclonal antibody collection with an aim of covering the majority of the human proteome.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories